Stocks End Mostly Lower on Vioxx Troubles
677746
NEW YORK - Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market...
626136
Drugs giant Merck and Co. shares plunged nearly 10 percent as the Wall Street Journal said the firm had fought for years to minimize the risks in its blockbuster pain drug Vioxx.
64708
Shares of Merck &amp; Co. plunged nearly 27 percent yesterday, pulling other stocks down with it, after the pharmaceutical giant yanked its Vioxx arthritis drug off the market because of heart safety concerns.
581018
U.S. blue-chip stocks closed lower in  thin trade  on Thursday after data gave a mixed picture of the  U.S. economy and steel shares fell as investors worried that  slowing demand from China could depress prices.
10458
NEW YORK - Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck &amp; Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market.
444667
Pfizer&#39;s surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors&#39; concerns over the pharmaceutical sector.
226638
US STOCKS slipped yesterday as drug-maker Merck recalled its widely sold Vioxx arthritis drug, and oil resumed its climb to $50 a barrel.
691283
U.S. stocks edged lower on Thursday,   after the Dow briefly touched its record closing high on   renewed worries that a rebound in crude prices may hurt   corporate profits.,
55595
Tokyo stocks ended slightly lower on Friday as worries about record-high oil prices took the edge off investors&#39; appetite for recently battered technology issues such as Shin-Etsu Chemical Co. Ltd.
446232
U.S. stocks ended lower but off their worst levels for the session Friday, allowing the market to post its first weekly gain for the year as investors took comfort from a pickup in merger activity.
619354
U.S. stocks were knocked lower on  Thursday after drug maker Merck & Co.MRK.N, a member of the  blue-chip Dow, recalled its widely sold Vioxx arthritis drug  and oil resumed its climb to $50 a barrel.
469117
U.S. stocks ended lower on Thursday after a volatile trading session as investors continued to snap up safer assets like bonds, following Tuesday's global equities sell-off.
495886
Recession fears and weakness in the tech sector lead the Dow to end down 2%, the Nasdaq down nearly 4%.
563279
Merck&#39;s withdrawal of its arthritis treatment sent the stock tumbling more than 25 percent and pushed the Dow into deeply negative territory at the open Thursday.
692567
US stocks ended mixed today as only the tech-heavy Nasdaq managed to make gains in the face of higher crude oil prices and a rash of broker downgrades targeting some high-profile Dow shares.
63892
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove one of its best-selling arthritis drugs from the market due to serious health risks...
428974
Stocks fell on Friday, led by pharmaceutical shares after a US health official raised concerns about drug safety and a drop in chip-equipment makers following a ratings downgrade by Goldman Sachs.